adding glycine to tirzepatide Compounded glycine added to tirzepatide With

More Gastrointestinal Adverse Events Researchers in Canada conducted a study to compare the safety outcomes of GLP-1 like Semaglutide

BMJ 339:b2700b2700

Additional considerations when discontinuing: Diabetes management: Stopping semaglutide without an alternative glucose-lowering plan in place can lead to A1c increases and symptomatic hyperglycemia

Beyond diabetes and obesity, research is now underway to explore the potential of GLP-1 agonists for other conditions like kidney disease, heart failure, Alzheimers, Parkinsons, sleep apnea and drug addiction, she said

However, this meta-analysis included only one RCT 43 and one case-control study 51 for GLP-1RAs (but not the more recent semaglutide) 41

Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes